Vaccine Ontology
7398 terms(s) returned
Term Type: | Record: 6001 to 6050 of 7398 Records | Page: 121 of 148, First Previous Next Last | Show Records Per Page |
- herpes simplex virus type 2 vaccine
- herpesvirus of turkey vaccine vector
- herpesvirus vaccine vector
- hfq from Salmonella Typhimurium
- history of asthma
- horse EEV, VEV, WEV encephalomyelitis and West Nile Virus vaccine
- horse EEV, VEV, WEV encephalomyelitis-West Nile Virus Vaccine-Tetanus Toxoid
- horse Encephalomyelitis-Influenza-West Nile Virus vaccine
- horse encephalomyelitis EEV, VEV, and WEV combination vaccine
- horse vaccine
- host immune factor-induced control of intracellular replication of live attenuated vaccine
- host response to vaccine adjuvant
- host response to vaccine antigen
- host response to vaccine component
- host response to vaccine vaccine vector
- host survival to pathogen challenge after vaccination
- host susceptibility gene response to vaccine adverse event
- htrA from Salmonella Typhimurium
- htrA from Yersinia enterocolitica
- human ACPP
- human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
- human Rabies vaccine
- human adenovirus vaccine vector
- human adolescence age range at vaccination
- human adult age range at vaccination
- human age
- human age 1 to 2 months at vaccination
- human age 11 to 12 years at vaccination
- human age 12 to 23 months at vaccination
- human age 19 to 26 years at vaccination
- human age 2 to 3 years at vaccination
- human age 27 to 59 years at vaccination
- human age 4 months at vaccination
- human age 4 to 6 years at vaccination
- human age 6 months at vaccination
- human age 7 to 10 years at vaccination
- human age 7 to 11 months at vaccination
- human age range at vaccination
- human age within one month at vaccination
- human albumin cell culture residual in vaccine
- human apo B-100 peptide-2 protein vaccine
- human child age range at vaccination
- human gene
- human ifng
- human immunization objective
- human immunodeficiency virus vaccine
- human leukocyte antigen class I-modified peptide vaccine
- human papillomavirus vaccine
- human protein
- human senior age range at vaccination